Sector
PharmaceuticalsOpen
₹212Prev. Close
₹207.85Turnover(Lac.)
₹1.31Day's High
₹212Day's Low
₹197.2552 Week's High
₹39852 Week's Low
₹185.05Book Value
₹111.88Face Value
₹10Mkt Cap (₹ Cr.)
63.53P/E
14.96EPS
13.36Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 3.18 | 3.18 | 3.18 | 3.18 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 28.76 | 23.64 | 18.36 | 16.69 |
Net Worth | 31.94 | 26.82 | 21.54 | 19.87 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 22.67 | 21.28 | 16.59 | 15.44 |
yoy growth (%) | 6.55 | 28.24 | 7.45 | 0.7 |
Raw materials | -10.72 | -9.27 | -7.74 | -6.76 |
As % of sales | 47.29 | 43.56 | 46.64 | 43.79 |
Employee costs | -3.88 | -3.48 | -2.72 | -3.06 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 3.96 | 3.9 | 9.36 | 1.14 |
Depreciation | -0.05 | -0.02 | -0.31 | -0.55 |
Tax paid | -1.02 | -0.91 | -2.53 | -0.68 |
Working capital | -6.69 | 2.44 | 9.78 | -1.16 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.55 | 28.24 | 7.45 | 0.7 |
Op profit growth | 7.74 | 57.95 | 9.86 | 28.16 |
EBIT growth | 1.01 | -58.6 | 531.49 | 58.04 |
Net profit growth | -1.76 | -54.16 | 1,311.97 | 95.49 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.65 | 92.31 | 3,95,326.43 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,537.95 | 78.57 | 1,73,562.03 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,498.35 | 24.58 | 1,21,022.9 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,312.75 | 20.48 | 1,09,550.72 | 1,200.7 | 0.61 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,226.65 | 57.31 | 1,09,199.59 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director
Sunil Jain Kumar.
Whole Time Director
Sanjay Kumar Jain.
Managing Director
Rajesh Pokerna
Whole Time Director
Seema Jain
Independent Non Exe. Director
Pradeep Kumar Jain
Independent Non Exe. Director
Pravichandra Majumdar Popatlal
Independent Non Exe. Director
Rajiv Kakodkar
Independent Non Exe. Director
Manish Jain
Whole Time Director
Manish Kumar Jain
Company Sec. & Compli. Officer
Santosh Kumar Jha
Independent Non Exe. Director
Vinod Kumar Jain
Independent Non Exe. Director
Ashok Kumar Jain
Independent Non Exe. Director
Kodakandla Sudarshanam
Shed No 42 Phase II IDA,
Mallapur,
Telangana - 500076
Tel: 91-40-23437617/23437623
Website: http://www.vasundhararasayans.in
Email: vasundhararasayanslimited@gmail.com, info@vrlindia
214 RaghavaRatna Tow,
Chiragali Lane, Abids,
Hyderabad 500001
Tel: 91-040-23202465/2320
Website: www.cilsecurities.com
Email: cilsec@hotmail.com
Summary
Vasundhara Rasayans Limited was incorporated in March, 1987. The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual cap...
Read More
Reports by Vasundhara Rasayans Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.